Filing Details
- Accession Number:
- 0001062993-19-002408
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-24 19:23:05
- Reporting Period:
- 2019-05-22
- Accepted Time:
- 2019-05-24 19:23:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1297318 | Jyrki Mattila | C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2019-05-22 | 15,000 | $37.64 | 15,376 | No | 4 | M | Direct | |
Common Stock, $0.001 Par Value | Acquisiton | 2019-05-22 | 3,750 | $41.82 | 19,126 | No | 4 | M | Direct | |
Common Stock, $0.001 Par Value | Disposition | 2019-05-22 | 18,750 | $62.06 | 376 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-05-22 | 15,000 | $0.00 | 15,000 | $37.64 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-05-22 | 3,750 | $0.00 | 3,750 | $41.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-04-22 | No | 4 | M | Direct | |
11,250 | 2028-03-15 | No | 4 | M | Direct |
Footnotes
- The options were granted on April 22, 2015 and vested in four equal annual installments beginning on the first anniversary of the grant date.
- The options were granted on March 15, 2018, and vest in four equal annual installments beginning on the first anniversary of the grant date.